Detalles de la búsqueda
1.
Letter to Editor: "The Trajectory of Oral Mucositis in Head and Neck Cancer Patients Undergoing Radiotherapy and Its Influencing Factors".
Ear Nose Throat J;
: 1455613241249268, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38656170
2.
Pre-chemoradiotherapy high platelet counts predict jaw osteoradionecrosis in locally advanced nasopharyngeal carcinoma patients.
J Stomatol Oral Maxillofac Surg;
125(3S): 101838, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518893
3.
The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
Tomography;
10(1): 79-89, 2024 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250953
4.
Predictive potential of pan-immune-inflammation value / hemoglobin index as biomarker for osteoradionecrosis risk in locally advanced nasopharyngeal carcinomas.
J Stomatol Oral Maxillofac Surg;
125(6): 101786, 2024 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38286220
5.
Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
Int J Biol Markers;
39(1): 80-88, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38192114
6.
High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
Discov Oncol;
14(1): 230, 2023 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091179
7.
Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index.
Diagnostics (Basel);
13(23)2023 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38066835
8.
Pretreatment Masseter Muscle Volume Predicts Survival in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
J Clin Med;
12(21)2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37959329
9.
The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.
Cancers (Basel);
15(18)2023 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760482
10.
High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients.
Ther Clin Risk Manag;
18: 421-428, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35444422
11.
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.
Cancer Chemother Pharmacol;
88(5): 805-812, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312705
12.
A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.
Am J Clin Oncol;
44(7): 301-307, 2021 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33979100
13.
Prechemoradiotherapy Systemic Inflammation Response Index Stratifies Stage IIIB/C Non-Small-Cell Lung Cancer Patients into Three Prognostic Groups: A Propensity Score-Matching Analysis.
J Oncol;
2021: 6688138, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33552158
14.
Baseline Low Prognostic Nutritional Index Predicts Poor Survival in Locally Advanced Nasopharyngeal Carcinomas Treated With Radical Concurrent Chemoradiotherapy.
Ear Nose Throat J;
100(2): NP69-NP76, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31184210
15.
The Influence of Systemic Inflammation Response Index on Survival Outcomes of Limited-Stage Small-Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy.
J Oncol;
2020: 8832145, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33381177
16.
Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
J Immunol Res;
2020: 8628540, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33274245
17.
Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy.
J Oncol;
2020: 3127275, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33082783
18.
Half-dose bevacizumab experience in relapsed ovarian cancer patients in Turkey due to formal regulations: similar effectiveness with lower rate of hypertension.
J BUON;
25(4): 1928-1934, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33099934
19.
Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study.
J Oncol;
2020: 7083149, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32952557
20.
Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.
Gastroenterol Res Pract;
2020: 5701949, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32802045